Jul 16, 2018 11:57am EDT OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
Jun 11, 2018 8:00am EDT OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
May 18, 2018 9:12am EDT OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
Mar 23, 2018 8:00am EDT OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes
Mar 16, 2018 8:00am EDT OPKO Health Announces Landmark Study Showing 4KscoreĀ® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology